BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 34127508)

  • 1. Assessing Electronic Nicotine Delivery Systems Use at NCI-Designated Cancer Centers in the Cancer Moonshot-funded Cancer Center Cessation Initiative.
    D'Angelo H; Land SR; Mayne RG
    Cancer Prev Res (Phila); 2021 Aug; 14(8):763-766. PubMed ID: 34127508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tobacco Treatment Program Implementation at NCI Cancer Centers: Progress of the NCI Cancer Moonshot-Funded Cancer Center Cessation Initiative.
    D'Angelo H; Rolland B; Adsit R; Baker TB; Rosenblum M; Pauk D; Morgan GD; Fiore MC
    Cancer Prev Res (Phila); 2019 Nov; 12(11):735-740. PubMed ID: 31481540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pragmatic Application of the RE-AIM Framework to Evaluate the Implementation of Tobacco Cessation Programs Within NCI-Designated Cancer Centers.
    D'Angelo H; Ramsey AT; Rolland B; Chen LS; Bernstein SL; Fucito LM; Webb Hooper M; Adsit R; Pauk D; Rosenblum MS; Cinciripini PM; Joseph A; Ostroff JS; Warren GW; Fiore MC; Baker TB
    Front Public Health; 2020; 8():221. PubMed ID: 32596200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electronic nicotine delivery systems and/or electronic non-nicotine delivery systems for tobacco smoking cessation or reduction: a systematic review and meta-analysis.
    El Dib R; Suzumura EA; Akl EA; Gomaa H; Agarwal A; Chang Y; Prasad M; Ashoorion V; Heels-Ansdell D; Maziak W; Guyatt G
    BMJ Open; 2017 Feb; 7(2):e012680. PubMed ID: 28235965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using information technology to integrate tobacco use treatment in routine oncology care: Lessons learned from the U.S. Cancer Center Cessation Initiative Cancer Centers.
    Bird JE; Nguyen CV; Hohl SD; D'Angelo H; Pauk D; Adsit RT; Fiore M; Minion M; McCarthy D; Rolland B
    Implement Res Pract; 2023; 4():26334895231185374. PubMed ID: 37790167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Impact of the COVID-19 Pandemic on Tobacco Treatment Program Implementation at National Cancer Institute-Designated Cancer Centers.
    Hohl SD; Shoenbill KA; Taylor KL; Minion M; Bates-Pappas GE; Hayes RB; Nolan MB; Simmons VN; Steinberg MB; Park ER; Ashing K; Beneventi D; Sanderson Cox L; Goldstein AO; King A; Kotsen C; Presant CA; Sherman SE; Sheffer CE; Warren GW; Adsit RT; Bird JE; D'Angelo H; Fiore MC; Van Thanh Nguyen C; Pauk D; Rolland B; Rigotti NA
    Nicotine Tob Res; 2023 Jan; 25(2):345-349. PubMed ID: 35778237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electronic nicotine delivery systems: a policy statement from the American Association for Cancer Research and the American Society of Clinical Oncology.
    Brandon TH; Goniewicz ML; Hanna NH; Hatsukami DK; Herbst RS; Hobin JA; Ostroff JS; Shields PG; Toll BA; Tyne CA; Viswanath K; Warren GW
    J Clin Oncol; 2015 Mar; 33(8):952-63. PubMed ID: 25572671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electronic Nicotine Delivery Systems: An Updated Policy Statement from the American Association for Cancer Research and the American Society of Clinical Oncology.
    Herbst RS; Hatsukami D; Acton D; Giuliani M; Moushey A; Phillips J; Sherwood S; Toll BA; Viswanath K; Warren NJH; Warren GW; Alberg AJ
    Clin Cancer Res; 2022 Nov; 28(22):4861-4870. PubMed ID: 36287033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are electronic nicotine delivery systems helping cigarette smokers quit? Evidence from a prospective cohort study of U.S. adult smokers, 2015-2016.
    Weaver SR; Huang J; Pechacek TF; Heath JW; Ashley DL; Eriksen MP
    PLoS One; 2018; 13(7):e0198047. PubMed ID: 29985948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Operationalizing Leadership and Clinician Buy-In to Implement Evidence-Based Tobacco Treatment Programs in Routine Oncology Care: A Mixed-Method Study of the U.S. Cancer Center Cessation Initiative.
    Hohl SD; Bird JE; Nguyen CVT; D'Angelo H; Minion M; Pauk D; Adsit RT; Fiore M; Nolan MB; Rolland B
    Curr Oncol; 2022 Mar; 29(4):2406-2421. PubMed ID: 35448169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Electronic Nicotine Delivery System Use With Cigarette Smoking Relapse Among Former Smokers in the United States.
    Everard CD; Silveira ML; Kimmel HL; Marshall D; Blanco C; Compton WM
    JAMA Netw Open; 2020 Jun; 3(6):e204813. PubMed ID: 32501492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrating Tobacco Treatment Into Oncology Care: Reach and Effectiveness of Evidence-Based Tobacco Treatment Across National Cancer Institute-Designated Cancer Centers.
    Hohl SD; Matulewicz RS; Salloum RG; Ostroff JS; Baker TB; Schnoll R; Warren G; Bernstein SL; Minion M; Lenhoff K; Dahl N; Juon HS; Tsosie U; Fleisher L; D'Angelo H; Ramsey AT; Ashing KT; Rolland B; Nolan MB; Bird JE; Nguyen CVT; Pauk D; Adsit RT; Tindle HA; Shoenbill K; Yeung S; Presant CA; Wiseman KP; Wen KY; Chichester LA; Chen LS
    J Clin Oncol; 2023 May; 41(15):2756-2766. PubMed ID: 36473135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Research support for effective state and community tobacco control programme response to electronic nicotine delivery systems.
    Schmitt CL; Lee YO; Curry LE; Farrelly MC; Rogers T
    Tob Control; 2014 Jul; 23 Suppl 3(Suppl 3):iii54-7. PubMed ID: 24935899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Exploration of Smoking-to-Vaping Transition Attempts Using a "Smart" Electronic Nicotine Delivery System.
    Blank ML; Hoek J; George M; Gendall P; Conner TS; Thrul J; Ling PM; Langlotz T
    Nicotine Tob Res; 2019 Sep; 21(10):1339-1346. PubMed ID: 29878179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual use of electronic nicotine delivery systems (ENDS) and smoked tobacco: a qualitative analysis.
    Robertson L; Hoek J; Blank ML; Richards R; Ling P; Popova L
    Tob Control; 2019 Jan; 28(1):13-19. PubMed ID: 29419488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of potential electronic nicotine delivery system regulations on nicotine product selection.
    Pesko MF; Kenkel DS; Wang H; Hughes JM
    Addiction; 2016 Apr; 111(4):734-44. PubMed ID: 26639526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Public Health Policies on E-Cigarettes.
    Bhalerao A; Sivandzade F; Archie SR; Cucullo L
    Curr Cardiol Rep; 2019 Aug; 21(10):111. PubMed ID: 31463564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of E-cigarettes on Smoking and Related Outcomes in Veteran Smokers With Psychiatric Comorbidity.
    Valentine GW; Hefner K; Jatlow PI; Rosenheck RA; Gueorguieva R; Sofuoglu M
    J Dual Diagn; 2018; 14(1):2-13. PubMed ID: 29083287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electronic nicotine delivery system (electronic cigarette) awareness, use, reactions and beliefs: a systematic review.
    Pepper JK; Brewer NT
    Tob Control; 2014 Sep; 23(5):375-84. PubMed ID: 24259045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual use of cigarettes and electronic nicotine delivery systems during pregnancy and the risk of small for gestational age neonates.
    Cardenas VM; Ali MM; Fischbach LA; Nembhard WN
    Ann Epidemiol; 2020 Dec; 52():86-92.e2. PubMed ID: 32805398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.